Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.
At the operating level, EBITDA jumped 102.9% to ₹85.2 crore in the third quarter of this fiscal over ₹42 crore year-on-year. Shares of PG Electroplast Ltd ended at ₹840.00, up by ₹4.65, or 0.56%, on ...
STERIS plc reported its third-quarter earnings for fiscal year 2024, revealing a slight miss on earnings per share (EPS) but a notable revenue beat. The company posted an EPS of $2.32, just shy of the ...
Indian drugmaker Aurobindo Pharma reported a lower third-quarter profit on Thursday, as a spike in expenses more than offset strong demand for its generic drugs.